Pier Capital »

Vaxcyte shares owned by Pier Capital

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Pier Capital from 13F filings

Historical chart of Pier Capital investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Pier Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Pier Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 202k 62.80
2023-09-30 $10M 204k 50.98
2023-06-30 $10M 206k 49.94
2023-03-31 $7.6M 203k 37.48
2022-12-31 $5.3M 111k 47.95

More positions owned by Pier Capital

Hexcel Corp Common Stocks (HXL)
Evercore Common Stocks (EVR)
Vaxcyte Common Stocks (PCVX)
RayzeBio Common Stocks
Maximus Common Stocks (MMS)
Calix Common Stocks (CALX)
Fabrinet Common Stocks (FN)
Houlihan Lokey Common Stocks (HLI)
Installed Building Products Common Stocks (IBP)
Onespaworld Common Stocks (OSW)
MSA Safety Common Stocks (MSA)
Vertex Common Stocks (VERX)
Ollie s Bargain Outlet Holdings Common Stocks (OLLI)
Applied Industrial Tech Common Stocks (AIT)
Advanced Drainage Systems Common Stocks (WMS)

View all positions for Pier Capital

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte